On March 8, Cantel Medical (NYSE:CMN) released second-quarter earnings for the period ended Jan. 31.

  • Revenues increased by 9.1%, primarily led by improvement in the company's core infection prevention and control business.
  • Cantel showed strong bottom-line performance, with a 20% rise in income from continuing operations.
  • The company benefited from its investments in direct sales and service in endoscope reprocessing and supply-chain efficiencies in the recently started water purification segment.
  • R. Scott Jones was appointed as the new CEO and president.

(Figures in millions, except per-share data.)

Income Statement Highlights

Q2 2007

Q2 2006

Change

Sales

$51.6

$47.3

9.1%

Net Profit*

$2.3

$1.9

20.2%

EPS

$0.14

$0.11

27.3%

Diluted Shares

16.1

16.4

(1.9%)

*Income from continuing operations

Get back to basics with the income statement.

Margin Checkup

Q2 2007

Q2 2006

Change*

Gross Margin

37.8%

35.6%

2.2

Operating Margin

8.7%

8.5%

0.2

Net Margin

4.4%

4.0%

0.4

*Expressed in percentage points.

Margins are the earnings engine.

Balance Sheet Highlights

Assets

Q2 2007

Q2 2006

Change

Cash + ST Invest.

$16.7

$19.7

(15.2%)

Accounts Rec.

No Data

No Data

No Data

Inventory

No Data

No Data

No Data



Liabilities

Q2 2007

Q2 2006

Change

Accounts Payable

No Data

No Data

No Data

Long-Term Debt

$36.0

$61.5

(41.5%)



The balance sheet reflects the company's health.

Cash Flow Highlights

No data available. Lame.

Free cash flow is a Fool's best friend.

Related Foolishness:

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.